Ohio State completes first gene therapy for hemophilia B
Ohio State University Wexner Medical CenterRecently, a team at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) completed its first gene therapy for a patient with hemophilia B, the first at an adult medical center in Ohio.